JPM highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO platform delivering sustainable high growth Post author:admin Post published:January 27, 2026 Post category:uncategorized JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth You Might Also Like Hallucinations and nightmares could herald the onset of autoimmune diseases May 21, 2024 Breakthrough immunotherapy targets non-cancer cells to prevent breast cancer spread March 4, 2024 UChicago expands microbiome research capabilities with new manufacturing facility July 16, 2024